BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6849655)

  • 1. Corneal and conjunctival effects of monobenzone in patients with vitiligo.
    Hedges TR; Kenyon KR; Hanninen LA; Mosher DB
    Arch Ophthalmol; 1983 Jan; 101(1):64-8. PubMed ID: 6849655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amodiaquine ocular changes.
    Hirst LW; Sanborn G; Green WR; Miller NR; Heath WD
    Arch Ophthalmol; 1982 Aug; 100(8):1300-4. PubMed ID: 7103815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone keratopathy: drug-induced lipid storage disease.
    D'Amico DJ; Kenyon KR; Ruskin JN
    Arch Ophthalmol; 1981 Feb; 99(2):257-61. PubMed ID: 6258544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal and conjunctival crystals in paraproteinemia.
    Grossniklaus HE; Stulting RD; L'Hernault N
    Hum Pathol; 1990 Nov; 21(11):1181-3. PubMed ID: 2227925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced lipidoses of the cornea and conjunctiva.
    D'Amico DJ; Kenyon KR
    Int Ophthalmol; 1981 Aug; 4(1-2):67-76. PubMed ID: 6795140
    [No Abstract]   [Full Text] [Related]  

  • 6. Dermatitis produced by applications of monobenzone in patients with active vitiligo.
    Nordlund JJ; Forget B; Kirkwood J; Lerner AB
    Arch Dermatol; 1985 Sep; 121(9):1141-4. PubMed ID: 2931053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monobenzone, Superfade, vitiligo and confetti-like depigmentation.
    Catona A; Lanzer D
    Med J Aust; 1987 Mar; 146(6):320-1. PubMed ID: 3821640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal and conjunctival deposits in monoclonal gammopathy.
    Cherry PM; Kraft S; McGowan H; Ghosh M; Shenken E
    Can J Ophthalmol; 1983 Apr; 18(3):143-9. PubMed ID: 6409389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preinvasive carcinoma of the cornea and conjunctiva.
    Dark AJ; Streeten BW
    Br J Ophthalmol; 1980 Jul; 64(7):506-14. PubMed ID: 7426564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E prevents changes in the cornea and conjunctiva due to vitamin A deficiency.
    Fujikawa A; Gong H; Amemiya T
    Graefes Arch Clin Exp Ophthalmol; 2003 Apr; 241(4):287-97. PubMed ID: 12719990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone.
    Oakley AM
    Australas J Dermatol; 1996 May; 37(2):96-8. PubMed ID: 8687336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scanning electron microscopy of the normal and experimentally infected ocular surface.
    Hazlett LD; Wells PA; Berk RS
    Scan Electron Microsc; 1984; (Pt 3):1379-89. PubMed ID: 6505620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal and conjunctival pigmentation among workers engaged in manufacture of hydroquinone.
    ANDERSON B
    Arch Ophthal; 1947 Dec; 38(6):812-26. PubMed ID: 18919409
    [No Abstract]   [Full Text] [Related]  

  • 14. Corneal and conjunctival pigmentation among workers in hydroquinone.
    COGAN DG; GRANT WM
    Arch Ophthal; 1947 Dec; 38(6):847. PubMed ID: 18919413
    [No Abstract]   [Full Text] [Related]  

  • 15. Idiopathic bilateral lipid keratopathy.
    Alfonso E; Arrellanes L; Boruchoff SA; Ormerod LD; Albert DM
    Br J Ophthalmol; 1988 May; 72(5):338-43. PubMed ID: 3395592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of corneal epithelial lesion and keratoconjunctival pigmentation due to anticancer drug S-1.
    Kobashi H; Kamiya K; Shimizu K
    Jpn J Ophthalmol; 2011 Mar; 55(2):163-5. PubMed ID: 21400063
    [No Abstract]   [Full Text] [Related]  

  • 17. The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone.
    Arowojolu OA; Orlow SJ; Elbuluk N; Manga P
    Exp Dermatol; 2017 Jul; 26(7):637-644. PubMed ID: 28370349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical monobenzyl ether of hydroquinone is an effective and safe treatment for depigmentation of extensive vitiligo in the medium term: a retrospective cohort study of 53 cases.
    Tan ES; Sarkany R
    Br J Dermatol; 2015 Jun; 172(6):1662-1664. PubMed ID: 25556887
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incidence of conjunctival and corneal changes in dialysis patients].
    Emmerich KH; Vondracek D; Raidt H; Graefe U
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):419-20. PubMed ID: 3807246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal lipidosis in patients with the acquired immunodeficiency syndrome.
    Wilhelmus KR; Keener MJ; Jones DB; Font RL
    Am J Ophthalmol; 1995 Jan; 119(1):14-9. PubMed ID: 7825685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.